Intriguingly, KEGG pathway enrichment analysis revealed that BMI1-activated genes, but not BMI1-repressed genes, were associated with protein lysine degradation, prostate cancer, and several other cancers (Supplementary Fig. 5c). This evidence concerns the gene BMI1 and prostate carcinoma.